Skip to main content
GutCited

Aloe Vera (Inner Leaf Gel) : Irritable Bowel Syndrome (IBS)

C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。

Small RCTs show modest improvement in IBS symptoms. Conflicting results; some studies show no benefit over placebo.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Daloe\u002Dvera\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Small RCTs show modest improvement in IBS symptoms. Conflicting results; some studies show no benefit over placebo.

Key Study Findings

Review
Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Dose: None vs: None Outcome: None 効果: None None

対象集団: patients with IBS (review of plant extracts including peppermint oil, Iberogast, curcumin)

Review
Natural Products for the Treatment of Irritable Bowel Syndrome.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Patients with irritable bowel syndrome

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None vs: Various Outcome: IBS symptom improvement 効果: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

対象集団: Adult IBS patients

Controlled Clinical Trial n=43 4 weeks
Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with …
Dose: 5 g/d vs: None Outcome: None 効果: None None

対象集団: IBS patients

Randomized Controlled Trial n=160 Double-blind
Food supplements and diet as treatment options in irritable bowel syndrome.
Dose: None vs: Placebo Outcome: None 効果: None None

対象集団: IBS patients

Meta-Analysis
Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Dose: None vs: Placebo Outcome: efficacy of Western herbal medicines in the treatment … 効果: None None

対象集団: IBS patients

Key Statistics

3

研究数

250

参加者数

↔

Mixed

C

グレード

Referenced Papers

Neurogastroenterology and motility 2020 34 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
100-200 mL aloe vera inner leaf gel/juice per day, or 300-500 mg capsule
ibssupport:
100 mL twice daily for 1-3 months
constipation:
100-300 mg aloe latex (short-term only, maximum 1-2 weeks)

上限量: No established UL for inner leaf gel; aloe latex (anthraquinones) should be limited to 1-2 weeks

研究で検討された用量

用量 期間 効果 N
None -- Mixed --
None -- Mixed --
None -- Positive --
5 g/d 4 weeks Positive 43
None -- Positive 160
None -- Positive --
500 mg 2.0 weeks Positive --
None -- Mixed --

推奨摂取タイミング: Before meals; aloe latex should only be used short-term for constipation

Safety & Side Effects

報告されている副作用

  • ⚠ Diarrhea and abdominal cramps (especially with aloe latex/whole leaf products)
  • ⚠ Electrolyte imbalance (hypokalemia) with chronic laxative use
  • ⚠ Potential hepatotoxicity with long-term whole leaf consumption (rare)
  • ⚠ Allergic skin reactions in sensitive individuals

既知の相互作用

  • ● Digoxin (hypokalemia from laxative use may increase digoxin toxicity)
  • ● Diuretics (additive potassium loss with aloe latex)
  • ● Diabetes medications (aloe may lower blood sugar; monitor glucose)
  • ● Stimulant laxatives (additive laxative effect; avoid combining)
  • ● Anticoagulants (theoretical interaction due to platelet effects)

耐容上限摂取量: No established UL for inner leaf gel; aloe latex (anthraquinones) should be limited to 1-2 weeks

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Aloe Vera (Inner Leaf Gel) help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 250 participants, there is limited but promising evidence that Aloe Vera (Inner Leaf Gel) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is C (Some Evidence).
How much Aloe Vera (Inner Leaf Gel) should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 100-200 mL aloe vera inner leaf gel/juice per day, or 300-500 mg capsule. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Aloe Vera (Inner Leaf Gel)?
Reported side effects may include Diarrhea and abdominal cramps (especially with aloe latex/whole leaf products), Electrolyte imbalance (hypokalemia) with chronic laxative use, Potential hepatotoxicity with long-term whole leaf consumption (rare), Allergic skin reactions in sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Aloe Vera (Inner Leaf Gel) and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 250 total participants. The overall direction of effect is mixed.

References

  1. [1] Ploutarchos Pastras et al.. Nutrients. 2026. Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines. doi:10.3390/nu18020183 PubMed
  2. [2] Sheida Zeraattalab-Motlagh et al.. Nutr Rev. 2025. Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical … doi:10.1093/nutrit/nuae107 PubMed
  3. [3] Sophie Brigstocke et al.. Gastroenterol Hepatol (N Y). 2025. Natural Products for the Treatment of Irritable Bowel Syndrome. PubMed
  4. [4] Karin Ried et al.. Nutr Res. 2020. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. doi:10.1016/j.nutres.2020.02.008 PubMed
  5. [5] Eirini Dimidi et al.. Neurogastroenterol Motil. 2020. Food supplements and diet as treatment options in irritable bowel syndrome. doi:10.1111/nmo.13951 PubMed
  6. [6] Jason A Hawrelak et al.. Complement Ther Med. 2020. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. doi:10.1016/j.ctim.2019.102233 PubMed
  7. [7] Carmen Parisio et al.. Nutrients. 2019. Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin. doi:10.3390/nu12010022 PubMed
  8. [8] Amanda C Fifi et al.. Nutrients. 2018. Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials. doi:10.3390/nu10111715 PubMed
  9. [9] Seung Wook Hong et al.. J Neurogastroenterol Motil. 2018. Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. doi:10.5056/jnm18077 PubMed
  10. [10] Stine Størsrud et al.. J Gastrointestin Liver Dis. 2015. A Pilot Study of the Effect of Aloe barbadensis Mill. Extract (AVH200®) in Patients with Irritable Bowel Syndrome: a Randomized, … doi:10.15403/jgld.2014.1121.243.sst PubMed
  11. [11] Hossein Khedmat et al.. J Res Med Sci. 2013. Aloe vera in treatment of refractory irritable bowel syndrome: Trial on Iranian patients. PubMed
  12. [12] Azar Asadi-Shahmirzadi et al.. Chin J Integr Med. 2012. Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects. doi:10.1007/s11655-012-1027-9 PubMed
  13. [13] H A Hutchings et al.. ISRN Gastroenterol. 2011. A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. doi:10.5402/2011/206103 PubMed
  14. [14] K Davis et al.. Int J Clin Pract. 2006. Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome. doi:10.1111/j.1742-1241.2006.00980.x PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。